These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

119 related articles for article (PubMed ID: 17767851)

  • 21. Studies on the methylation status of CpG sequences located in promoters of selected tumour suppressor genes in breast cancer cells.
    Fabianowska-Majewska K; Kordek R; Krawczyk B
    Nucleosides Nucleotides Nucleic Acids; 2006; 25(9-11):1025-8. PubMed ID: 17065058
    [TBL] [Abstract][Full Text] [Related]  

  • 22. CpG hypomethylation of MDR1 gene in tumor and serum of invasive ductal breast carcinoma patients.
    Sharma G; Mirza S; Parshad R; Srivastava A; Datta Gupta S; Pandya P; Ralhan R
    Clin Biochem; 2010 Mar; 43(4-5):373-9. PubMed ID: 19879256
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Microarray-based methylation analysis using dual-color fluorescence hybridization.
    Zhou D; Qiao W; Wan Y; Lu Z
    J Biochem Biophys Methods; 2006 Mar; 66(1-3):33-43. PubMed ID: 16442635
    [TBL] [Abstract][Full Text] [Related]  

  • 24. GSTP1 promoter haplotypes affect DNA methylation levels and promoter activity in breast carcinomas.
    Rønneberg JA; Tost J; Solvang HK; Alnaes GI; Johansen FE; Brendeford EM; Yakhini Z; Gut IG; Lønning PE; Børresen-Dale AL; Gabrielsen OS; Kristensen VN
    Cancer Res; 2008 Jul; 68(14):5562-71. PubMed ID: 18632608
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Expression and promoter methylation of the RASSF1A gene in sporadic breast cancers in Chinese women.
    Li Y; Wei Q; Cao F; Cao X
    Oncol Rep; 2008 May; 19(5):1149-53. PubMed ID: 18425370
    [TBL] [Abstract][Full Text] [Related]  

  • 26. RUNX3 inactivation by frequent promoter hypermethylation and protein mislocalization constitute an early event in breast cancer progression.
    Subramaniam MM; Chan JY; Soong R; Ito K; Ito Y; Yeoh KG; Salto-Tellez M; Putti TC
    Breast Cancer Res Treat; 2009 Jan; 113(1):113-21. PubMed ID: 18256927
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Methylated genes as new cancer biomarkers.
    Duffy MJ; Napieralski R; Martens JW; Span PN; Spyratos F; Sweep FC; Brunner N; Foekens JA; Schmitt M;
    Eur J Cancer; 2009 Feb; 45(3):335-46. PubMed ID: 19138839
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Aberrant DNA methylation profile and frequent methylation of KLK10 and OXGR1 genes in hepatocellular carcinoma.
    Lu CY; Hsieh SY; Lu YJ; Wu CS; Chen LC; Lo SJ; Wu CT; Chou MY; Huang TH; Chang YS
    Genes Chromosomes Cancer; 2009 Dec; 48(12):1057-68. PubMed ID: 19760608
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Novel methylation and expression markers associated with breast cancer].
    Kuznetsova EB; Kekeeva TV; Larin SS; Zemliakova VV; Babenko OV; Nemtsova MV; Zaletaev DV; Strel'nikov VV
    Mol Biol (Mosk); 2007; 41(4):624-33. PubMed ID: 17936981
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Prognostic implications of and relationship between CpG island hypermethylation and repetitive DNA hypomethylation in hepatocellular carcinoma.
    Lee HS; Kim BH; Cho NY; Yoo EJ; Choi M; Shin SH; Jang JJ; Suh KS; Kim YS; Kang GH
    Clin Cancer Res; 2009 Feb; 15(3):812-20. PubMed ID: 19188151
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Promoter hypermethylation and loss of heterozygosity of the APC gene in patients with familial adenomatous polyposis].
    Zhang YY; Chen SQ; Zhu M; Li JT; Ma GJ; Zhang XM; Zhou JN
    Zhonghua Yi Xue Yi Chuan Xue Za Zhi; 2008 Aug; 25(4):378-81. PubMed ID: 18683131
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Multigene methylation in serum of sporadic Chinese female breast cancer patients as a prognostic biomarker.
    Jing F; Jun L; Yong Z; Wang Y; Fei X; Zhang J; Hu L
    Oncology; 2008; 75(1-2):60-6. PubMed ID: 18784433
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Vimentin methylation as a marker for advanced colorectal carcinoma.
    Shirahata A; Sakata M; Sakuraba K; Goto T; Mizukami H; Saito M; Ishibashi K; Kigawa G; Nemoto H; Sanada Y; Hibi K
    Anticancer Res; 2009 Jan; 29(1):279-81. PubMed ID: 19331162
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Methylation of p16 CpG island associated with malignant progression of oral epithelial dysplasia: a prospective cohort study.
    Cao J; Zhou J; Gao Y; Gu L; Meng H; Liu H; Deng D
    Clin Cancer Res; 2009 Aug; 15(16):5178-83. PubMed ID: 19671846
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Epigenetic alterations of CDH1 and APC genes: relationship with activation of Wnt/beta-catenin pathway in invasive ductal carcinoma of breast.
    Prasad CP; Mirza S; Sharma G; Prashad R; DattaGupta S; Rath G; Ralhan R
    Life Sci; 2008 Aug; 83(9-10):318-25. PubMed ID: 18662704
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Methylation of the MGMT and p16 genes in sporadic colorectal carcinoma and corresponding normal colonic mucosa.
    Krakowczyk L; Strzelczyk JK; Adamek B; Zalewska-Ziob M; Arendt J; Półtorak S; Maciejewski B; Wiczkowski A
    Med Sci Monit; 2008 Oct; 14(10):BR219-25. PubMed ID: 18830187
    [TBL] [Abstract][Full Text] [Related]  

  • 37. DNA methylation profile in diffuse type gastric cancer: evidence for hypermethylation of the BRCA1 promoter region in early-onset gastric carcinogenesis.
    Bernal C; Vargas M; Ossandón F; Santibáñez E; Urrutia J; Luengo V; Zavala LF; Backhouse C; Palma M; Argandoña J; Aguayo F; Corvalán A
    Biol Res; 2008; 41(3):303-15. PubMed ID: 19399343
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Progesterone receptor B (PRB) promoter hypermethylation in sporadic breast cancer: progesterone receptor B hypermethylation in breast cancer.
    Mc Cormack O; Chung WY; Fitzpatrick P; Cooke F; Flynn B; Harrison M; Fox E; Gallagher E; McGoldrick A; Dervan PA; McCann A; Kerin MJ
    Breast Cancer Res Treat; 2008 Sep; 111(1):45-53. PubMed ID: 17896177
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Multicenter study using paraffin-embedded tumor tissue testing PITX2 DNA methylation as a marker for outcome prediction in tamoxifen-treated, node-negative breast cancer patients.
    Harbeck N; Nimmrich I; Hartmann A; Ross JS; Cufer T; Grützmann R; Kristiansen G; Paradiso A; Hartmann O; Margossian A; Martens J; Schwope I; Lukas A; Müller V; Milde-Langosch K; Nährig J; Foekens J; Maier S; Schmitt M; Lesche R
    J Clin Oncol; 2008 Nov; 26(31):5036-42. PubMed ID: 18711169
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Quantification of methylation of SNCG CpG islands in human tissue samples by the combined COBRA-DHPLC assay].
    Zhou J; Wen XZ; Deng DJ
    Zhonghua Yu Fang Yi Xue Za Zhi; 2007 Jun; 41 Suppl():20-4. PubMed ID: 17767852
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.